Elite Pharmaceuticals, Inc. (ELTP)
0.2551
-0.01
(-3.74%)
USD |
OTCM |
Oct 09, 16:00
Elite Pharmaceuticals Free Cash Flow (Quarterly) : 9.261M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.261M |
| March 31, 2026 | 8.748M |
| December 31, 2025 | -5.484M |
| September 30, 2025 | 5.001M |
| June 30, 2025 | 14.56M |
| March 31, 2025 | 3.164M |
| December 31, 2024 | -1.064M |
| September 30, 2024 | 1.364M |
| June 30, 2024 | 1.466M |
| March 31, 2024 | 1.656M |
| December 31, 2023 | -2.802M |
| September 30, 2023 | -0.2359M |
| June 30, 2023 | -2.710M |
| March 31, 2023 | 2.432M |
| December 31, 2022 | -0.5686M |
| September 30, 2022 | -3.610M |
| June 30, 2022 | -0.6521M |
| March 31, 2022 | 1.341M |
| December 31, 2021 | 2.952M |
| September 30, 2021 | 0.0064M |
| June 30, 2021 | 1.710M |
| March 31, 2021 | -0.9343M |
| December 31, 2020 | 1.185M |
| September 30, 2020 | 1.820M |
| June 30, 2020 | 0.7934M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.238M |
| December 31, 2019 | -0.3122M |
| September 30, 2019 | -0.464M |
| June 30, 2019 | 0.1853M |
| March 31, 2019 | -2.136M |
| December 31, 2018 | -1.287M |
| September 30, 2018 | -1.500M |
| June 30, 2018 | -1.888M |
| March 31, 2018 | -0.9117M |
| December 31, 2017 | -0.3929M |
| September 30, 2017 | -2.352M |
| June 30, 2017 | -1.427M |
| March 31, 2017 | -4.369M |
| December 31, 2016 | -1.019M |
| September 30, 2016 | -2.552M |
| June 30, 2016 | -1.049M |
| March 31, 2016 | 0.0356M |
| December 31, 2015 | -1.738M |
| September 30, 2015 | -4.186M |
| June 30, 2015 | 1.174M |
| March 31, 2015 | -4.455M |
| December 31, 2014 | -2.990M |
| September 30, 2014 | -4.757M |
| June 30, 2014 | -4.898M |
| March 31, 2014 | -1.578M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Daré Bioscience, Inc. | -6.856M |
| Eton Pharmaceuticals, Inc. | 7.26M |
| ANI Pharmaceuticals, Inc. | 53.62M |
| Corcept Therapeutics, Inc. | 31.02M |
| Veru, Inc. | -5.467M |